Tuberous sclerosis

Last updated: June 19, 2025

Tuberous sclerosis

Paeds

Paeds

Newborn management: Clinical
Congenital TORCH infections: Pathology review
Perinatal infections: Clinical
Congenital heart defects: Clinical
Miscellaneous genetic disorders: Pathology review
Disorders of amino acid metabolism: Pathology review
Glycogen storage disorders: Pathology review
Lysosomal storage disorders: Pathology review
Disorders of fatty acid metabolism: Pathology review
Disorders of carbohydrate metabolism: Pathology review
Autosomal trisomies: Pathology review
Congenital disorders: Clinical
Neonatal jaundice: Clinical
Neonatal ICU conditions: Clinical
Immunodeficiencies: Clinical
Pediatric allergies: Clinical
Kawasaki disease: Clinical
Pediatric ear, nose, and throat conditions: Clinical
Congenital adrenal hyperplasia: Clinical
Pediatric constipation: Clinical
Pediatric gastrointestinal bleeding: Clinical
Pediatric vomiting: Clinical
Developmental milestones: Clinical
Vaccinations: Clinical
Precocious and delayed puberty: Clinical
Disorders of sex chromosomes: Pathology review
Child abuse: Clinical
Disorders of sexual development and sex hormones: Pathology review
Sickle cell disease: Clinical
Pediatric infectious rashes: Clinical
Skin and soft tissue infections: Clinical
Pediatric bone and joint infections: Clinical
Viral exanthems of childhood: Pathology review
Pediatric urological conditions: Clinical
Elimination disorders: Clinical
Neurodevelopmental disorders: Clinical
Seizures: Clinical
Brain tumors: Clinical
Pediatric ophthalmological conditions: Clinical
Pediatric upper airway conditions: Clinical
Pediatric lower airway conditions: Clinical
Cystic fibrosis: Clinical
BRUE, ALTE, and SIDS: Clinical
Pediatric orthopedic conditions: Clinical
Pediatric bone tumors: Clinical
Muscular dystrophies and mitochondrial myopathies: Pathology review
Kawasaki disease
Behcet's disease
Coarctation of the aorta
Polycystic kidney disease
Persistent truncus arteriosus
Transposition of the great vessels
Total anomalous pulmonary venous return
Tetralogy of Fallot
Hypoplastic left heart syndrome
Patent ductus arteriosus
Ventricular septal defect
Atrial septal defect
Endocarditis
Rheumatic heart disease
Myocarditis
Acyanotic congenital heart defects: Pathology review
Cyanotic congenital heart defects: Pathology review
Valvular heart disease: Pathology review
Endocarditis: Pathology review
Congenital adrenal hyperplasia
Thyroglossal duct cyst
Diabetes mellitus
Diabetic nephropathy
Gigantism
Acromegaly
Constitutional growth delay
Precocious puberty
Delayed puberty
Premature ovarian failure
Polycystic ovary syndrome
Androgen insensitivity syndrome
Kallmann syndrome
5-alpha-reductase deficiency
Neuroblastoma
Diabetes mellitus: Pathology review
Retinoblastoma
Retinopathy of prematurity
Otitis externa
Otitis media
Choanal atresia
Allergic rhinitis
Laryngomalacia
Laryngitis
Bacterial epiglottitis
Cleft lip and palate
Esophageal web
Pyloric stenosis
Congenital diaphragmatic hernia
Tracheoesophageal fistula
Gastritis
Necrotizing enterocolitis
Intussusception
Appendicitis
Crigler-Najjar syndrome
Gilbert's syndrome
Rotor syndrome
Biliary atresia
Dubin-Johnson syndrome
Neonatal hepatitis
Congenital gastrointestinal disorders: Pathology review
Appendicitis: Pathology review
Viral hepatitis: Pathology review
Jaundice: Pathology review
Iron deficiency anemia
Beta-thalassemia
Alpha-thalassemia
Sideroblastic anemia
Anemia of chronic disease
Lead poisoning
Hemolytic disease of the newborn
Glucose-6-phosphate dehydrogenase (G6PD) deficiency
Autoimmune hemolytic anemia
Pyruvate kinase deficiency
Paroxysmal nocturnal hemoglobinuria
Sickle cell disease (NORD)
Hereditary spherocytosis
Aplastic anemia
Fanconi anemia
Megaloblastic anemia
Folate (Vitamin B9) deficiency
Vitamin B12 deficiency
Diamond-Blackfan anemia
Hemophilia
Hemolytic-uremic syndrome
Acute leukemia
Myeloproliferative disorders: Pathology review
Neonatal sepsis
Asthma
Poststreptococcal glomerulonephritis
Contact dermatitis
Atopic dermatitis
Human herpesvirus 6 (Roseola)
Varicella zoster virus
Rubella virus
Parvovirus B19
Measles virus
Radial head subluxation (Nursemaid elbow)
Developmental dysplasia of the hip
Legg-Calve-Perthes disease
Slipped capital femoral epiphysis
Transient synovitis
Osgood-Schlatter disease (traction apophysitis)
Spina bifida
Dandy-Walker malformation
Tethered spinal cord syndrome
Septo-optic dysplasia
Spinocerebellar ataxia (NORD)
Chiari malformation
Syringomyelia
Aqueductal stenosis
Cerebral palsy
Shaken baby syndrome
Seizures and epilepsy
Early infantile epileptic encephalopathy (NORD)
Febrile seizure
Pediatric brain tumors
Neonatal meningitis
Meningitis
Neurofibromatosis
Tuberous sclerosis
Sturge-Weber syndrome
von Hippel-Lindau disease
Congenital neurological disorders: Pathology review
Seizures: Pathology review
Pediatric brain tumors: Pathology review
Renal agenesis
Potter sequence
Horseshoe kidney
Posterior urethral valves
Vesicoureteral reflux
Hypospadias and epispadias
Bladder exstrophy
Congenital renal disorders: Pathology review
Nephrotic syndromes: Pathology review
Nephritic syndromes: Pathology review
Urinary tract infections: Pathology review
Electrolyte disturbances: Pathology review
Acid-base disturbances: Pathology review
Klinefelter syndrome
Turner syndrome
Amenorrhea: Pathology review
Congenital pulmonary airway malformation
HIV (AIDS)

Transcript

Watch video only

Tuberous sclerosis is a genetic condition that causes growths to form in various body organs. Most commonly affecting the brain, skin, kidneys, lungs, and eyes.

Normally, there are two genes called TSC1 and TSC2 that help control the growth and division of cells in the body.

TSC1 encodes the protein hamartin and TSC2 encodes the protein tuberin.

Both of these proteins, are tumor suppressors, meaning they help slow down cell growth and prevent tumors.

They do this by combining to form a hamartin-tuberin protein complex, which binds to and inhibits another protein called mechanistic target of rapamycin, or mTOR.

mTOR activity speeds up the cell cycle and increases cell proliferation mainly thanks to its effect on protein synthesis.

So when mTOR is switched off by the hamartin-tuberin protein complex, it slows growth and division of cells throughout the body.

Individuals with tuberous sclerosis have a mutation in either the gene TSC1 or TSC2, and these mutations have an autosomal dominant inheritance pattern.

The mutations lead to an altered hamartin-tuberin protein complex that’s unable to switch off mTOR.

Because of that, benign tumors and growths called hamartomas form throughout the body.

Hamartomas are kind of like tumors, but they’re made of a variety of cell types from the tissue where they arise, rather than a single cell type.

In fact, if we think of the tissue like a sheet of fabric, a hamartoma is like a knot in the sheet.

Benign tumors and hamartomas can form in any tissue, but the brain and the skin are usually affected the most, along with the kidneys, lungs and eyes.

On top of that the lifetime risk of cancer is increased in individuals with tuberous sclerosis.

That’s because the rapidly dividing cells can develop additional mutations that eventually make these growths expand beyond the basement membrane and invade neighboring tissues.

In the brain, the most common growths are glioneural hamartomas, also known as a cortical tubers. They arise from supportive glial cells as well as neurons.

Next most common are subependymal nodules, which are hamartomas that form under the ependyma, the thin membrane that lines the ventricles in the brain.

Individuals are also at an increased risk of developing a subependymal giant cell astrocytoma, or SEGA, which is a type of cancer that can arise from the subependymal nodules.

Key Takeaways

Tuberous sclerosis, also known as tuberous sclerosis complex (TSC), is a rare genetic disorder that causes noncancerous tumors to grow in various parts of the body. The condition is caused by mutations in one of two genes, TSC1 or TSC2, which are responsible for regulating cell growth and division.

TSC can affect multiple organs, including the brain, skin, kidneys, heart, and lungs. Symptoms vary widely depending on the location and size of the tumors but may include seizures, intellectual disability, developmental delays, skin lesions, kidney problems, and lung complications.

Diagnosis of TSC typically involves a combination of clinical evaluation, imaging studies, and genetic testing. Treatment may involve a variety of interventions depending on the specific symptoms and organ involvement, such as antiepileptic medications for seizures, surgical removal of tumors, or targeted therapies to block cell growth in affected organs.

Sources

  1. "Robbins Basic Pathology" Elsevier (2017)
  2. "Harrison's Principles of Internal Medicine, Twentieth Edition (Vol.1 & Vol.2)" McGraw-Hill Education / Medical (2018)
  3. "Pathophysiology of Disease: An Introduction to Clinical Medicine 8E" McGraw-Hill Education / Medical (2018)
  4. "CURRENT Medical Diagnosis and Treatment 2020" McGraw-Hill Education / Medical (2019)
  5. "A clinical update on tuberous sclerosis complex‐associated neuropsychiatric disorders (TAND)" American Journal of Medical Genetics Part C: Seminars in Medical Genetics (2018)
  6. "Renal manifestations of tuberous sclerosis complex: Incidence, prognosis, and predictive factors" Kidney International (2006)
  7. "Abnormal glycogen storage in tuberous sclerosis complex caused by impairment of mTORC1-dependent and -independent signaling pathways" Proceedings of the National Academy of Sciences (2019)
  8. "Tuberous Sclerosis Complex Diagnostic Criteria Update: Recommendations of the 2012 International Tuberous Sclerosis Complex Consensus Conference" Pediatric Neurology (2013)